10-YEAR FOLLOW-UP OF PATIENTS WITH POOR PROGNOSIS GERM CELL TUMOR TREATED WITH FIRST-LINE LATE-INTENSIFICATION HIGH-DOSE CHEMOTHERAPY

被引：0
|
作者：
Papiani, Giorgio [1 ]
De Giorgi, Ugo [1 ]
Marangolo, Maurizio [1 ]
Rosti, Giovanni [1 ]
机构：
[1] Santa Maria delle Croci Hosp, Dept Hematol Oncol, Ravenna, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：91 / 91
页数：1
相关论文
共 50 条
  • [31] 10-Year follow-up of 621 patients treated using high-dose rate brachytherapy as ambulatory boost technique in conservative breast cancer treatment
    Quero, Laurent
    Guillerm, Sophie
    Taright, Naila
    Michaud, Sophie
    Teixeira, Luis
    Cahen-Doidy, Laurence
    Bourstyn, Edwige
    Espie, Marc
    Hennequin, Christophe
    RADIOTHERAPY AND ONCOLOGY, 2017, 122 (01) : 11 - 16
  • [32] Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma-a long-term follow-up study
    Kasenda, B.
    Schorb, E.
    Fritsch, K.
    Finke, J.
    Illerhaus, G.
    ANNALS OF ONCOLOGY, 2012, 23 (10) : 2670 - 2675
  • [33] High-dose chemotherapy with haematopoietic stem-cell support in patients with poor prognosis, relapsed or refractory germ cell tumours
    El-Helw, Loale M.
    Naik, Jay D.
    Chester, John D.
    Joffe, Johnathan K.
    Selby, Peter J.
    Coleman, Robert E.
    BJU INTERNATIONAL, 2006, 98 (03) : 519 - 525
  • [34] Outcome in 41 patients with late relapse germ cell tumors (GCT) treated with high-dose chemotherapy (HDCT)
    Lorch, A.
    Rick, O.
    Hartmann, J. T.
    Metzner, B.
    Glasmacher, A.
    Berdel, W.
    Schirren, R.
    Bokemeyer, C.
    Beyer, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [35] Chemotherapy for osteosarcoma without high-dose methotrexate: A 12-year follow-up on 53 patients
    Tunn, Per-Ulf
    Reichardt, Peter
    ONKOLOGIE, 2007, 30 (05): : 228 - 232
  • [36] High Endogenous DNA Damage Levels Predict Hematological Toxicity in Testicular Germ Cell Tumor Patients Treated With First-Line Chemotherapy
    Hapakova, Nikola
    Sestakova, Zuzana
    Holickova, Andrea
    Hurbanova, Lenka
    Miskovska, Vera
    Chovanec, Michal
    Rejlekova, Katarina
    Svetlovska, Daniela
    Kalavska, Katarina
    Obertova, Jana
    Palacka, Patrik
    Sycova-Mila, Zuzana
    Mardiak, Jozef
    Chovanec, Miroslav
    Mego, Michal
    CLINICAL GENITOURINARY CANCER, 2019, 17 (05) : E1020 - E1025
  • [37] First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial
    Bokemeyer, C
    Schleucher, N
    Metzner, B
    Thomas, M
    Rick, O
    Schmoll, HJ
    Kollmannsberger, C
    Boehlke, I
    Kanz, L
    Hartmann, JT
    BRITISH JOURNAL OF CANCER, 2003, 89 (01) : 29 - 35
  • [38] First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial
    C Bokemeyer
    N Schleucher
    B Metzner
    M Thomas
    O Rick
    H-J Schmoll
    C Kollmannsberger
    I Boehlke
    L Kanz
    J T Hartmann
    British Journal of Cancer, 2003, 89 : 29 - 35
  • [39] First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis
    Bokemeyer, C
    Kollmannsberger, C
    Meisner, C
    Harstrick, A
    Beyer, J
    Metzner, B
    Hartmann, JT
    Schmoll, HL
    Einhorn, L
    Kanz, L
    Nichols, C
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (11) : 3450 - 3456
  • [40] Long-term outcome of salvage high-dose chemotherapy in patients with germ cell tumor with poor prognostic features
    De Giorgi, Ugo
    Rosti, Giovanni
    Salvioni, Roberto
    Papiani, Giorgio
    Ballardini, Michela
    Pizzocaro, Giorgio
    Marangolo, Maurizio
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2011, 29 (03) : 284 - 290
12345